Unum is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immunotherapies designed to harness the power of a patient's immune system to cure cancer.
In order to optimize our website for you and to be able to continuously improve it, we use cookies. By continuing to use the website, you agree to the use of cookies. Further information on cookies can be found in our Privacy Policy.